Recent performance snapshot AstraZeneca (LSE:AZN) has drawn fresh investor attention after a period of solid share price ...
AstraZeneca (LSE:AZN) reported that its monoclonal antibody tozorakimab met primary endpoints in two Phase III COPD trials.
Assessing AstraZeneca after recent share price moves AstraZeneca (LSE:AZN) has experienced mixed share price movements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results